AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05686811 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Myofascial release therapy therapy
Description: Group A was treated with myofascial release therapy and routine physical therapy. For routine physical therapy subjects will first applied TENS, hot pack and neck isometric exercises then myofascial release therapy will be given. For myofascial release therapy subjects was in the supine or possibly sitting position, the examiner was seated at the head of the table, the examiner was used his right thumb to palpate (using flat palpation) the upper trapezius muscles from medial to lateral to establish if any MTrPs are present. The entire mass of the upper trapezius muscle is lifted by the supraspinatus muscle and grasped with a pincer grasp. The muscles at this point rotate between the thumb and forefinger to detect the delicate location of the trigger point. Treatment session longs for 10 minutes of myofascial release on each side
Study NCT05686811 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Post isometric relaxation technique
Description: This group will receive routine physical therapy with myofascial release therapy.This protocol will be given for 3 alternative days per week. Each session will be of 40 minutes. Data will be calculated at baseline , at 2nd and at 4th week.
Study NCT04644081 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: LTP
Description: LTP is a low-literacy, sustainable programme that will provide depressed mothers with valuable skills on parenting, improve mother-child relation and mental health self-care. This is a research-based activity that enhances postpartum mental health while simultaneously promoting attachment security through building parents' ability to monitor and be sensitive to their children's cues, and thereby, actively involves in their children's mental and physical development.
Study NCT06455423 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Thoracic Manipulation
Description: Thoracic manipulation will be administered at hypomobile or stiff segments.
Study NCT06455423 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Thoracic Manipulation
Description: Thoracic manipulation will be administered at hypomobile or stiff segments.
Study NCT06455423 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Chin tuck in exercises
Description: Chin tuck in exercises
Study NCT04644081 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CaCBT
Description: CaCBT adopts 'here and now' problem-solving approach, which involves collaborating with families, active listening techniques, changing negative thinking, and depressive symptoms associated with postnatal depression and other forms of parenting distress.
Study NCT04644081 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: TAU
Description: TAU is the routine care currently available for the treatment of postnatal depression at the primary health care sites of intervention (e.g. antidepressants and other forms of mental health care).
Study NCT06505317 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: AI-based PAD screening intervention
Description: Providers will receive alerts for a patient that is flagged by model as being high risk for PAD. This will allow the provider to review the alert, check the patient's previous history, develop additional questions to assess the risk of PAD, and initiate orders prior to seeing a patient. Depending on their assessment during the patient visit the provider may choose to order an ABI test (or perform one at bedside) and/or initiate other secondary prevention measures. All patients for which an alert is triggered will be included for secondary analysis.
Study NCT05613595 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Positive Psychotherapy
Description: Positive Psychotherapy is an effective treatment for many mental disorders and depression is primary empirical target. Its primary goal is to build positive emotion, engagement, and meaning in life that will alleviate depression and other mental health disorders. Thus PPT may offer a new way to treat and prevent mental health issues.~Interventions sessions included, Session Records Session One: Positive Introduction and Gratitude Journal Session Two: Character Strengths and Signature Strengths Session Three: Practical Wisdom , Session Four: A Better Version of Me , Session Five: Open and Closed Memories, Session Six: Forgiveness Session Seven: Maximizing versus Satisficing, Session Eight: Gratitude ,Session Nine: Hope and Optimism, Session Ten: Posttraumatic Growth, Session Eleven: Slowness and Savoring, Session Twelve: Positive Relationships, Session Thirteen: Positive Communication, Session Fourteen: Altruism , Session Fifteen: Meaning and Purpose
Study NCT05613595 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Counseling Group
Description: Caregivers in control group only regular counseling will be provided (psychoeducation). it will be based upon the insight of cerebral palsy and training based on Adaptive skill functioning of the CP child of the caregivers
Study NCT04881175 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Non-Invasive Treatment
Description: Single-arm group using the FlexSure Applicator device.
Study NCT06140732 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: camrelizumab and apatinib
Description: camrelizumab 200 mg iv/ q2w+ apatinib 375mg oral qd
Study NCT04664270 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: e-CBT
Description: e-CBT + Mindfulness + Problem Solving
Study NCT06321952 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: ROSA robotic assist TKA
Description: total knee replacement with ROSA robotic assist
Study NCT06321952 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: iassist TKA
Description: total knee replacement with iassist
Study NCT06226948 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CGM
Description: Participants will wear CGM monitors for 10 days.
Study NCT06226948 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Visualization
Description: Enriched visualization of SCORE2 CVD risk.
Study NCT04647253 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: AGENT DCB
Description: Drug coated PTCA balloon catheter
Study NCT04647253 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: PTCA balloon catheter
Description: PTCA balloon catheter
Study NCT06709521 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Iohexol
Description: Iohexol,N,N´ -Bis(2,3-dihydroxypropyl)-5-\[N-(2,3-dihydroxypropyl)-acetamido\]-2,4,6-triiodoisophthalamide, is a non-ionic, water-soluble radiographic contrast medium with a molecular weight of 821.14 (iodine content 46.36%)
Study NCT06709781 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Control (no cooling modalities)
Description: Subjects will exercise for 60 minutes in the heat while being exposed to no cooling modality.
Study NCT06709781 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Water Spray and Fan
Description: Subjects will exercise for 60 minutes in the heat while being exposed to a combination of skin wetting and a fan. The fan will be a commercially available fan will be directed to the research subject throughout the exercise bout. Skin wetting will be performed by spraying water onto the skin throughout the exercise bout.
Study NCT06057402 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Elranatamab
Description: Elranatamab is a heterodimeric humanized full-length bispecific IgG2 kappa antibody that targets BCMA on MM cells and CD3 on T cells
Study NCT06719544 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: lithium carbonate
Description: Oral capsule
Study NCT06719544 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: enlicitide
Description: Oral tablet
Study NCT06723665 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 18F-PSMA-1007
Description: 18F-PSMA-1007 is administered through a superficial dorsal vein, and the patient is given a dose of about 0.1-0.15mCi/kg
Study NCT06723665 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 18F-FDG
Description: 18F-FDG is administered through a superficial dorsal vein, and the patient is given a dose of about 0.1-0.15mCi/kg
Study NCT05839730 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Pacemaker PLR + TRT ON
Description: RAMware modified implantable pulse generator (IPG) with personalized lower rate (PLR) and tachycardia remodeling therapy (TRT) ON
Study NCT05839730 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Pacemaker non-pacing mode or an exertional rate-adaptive pacing mode with no planned pacing at rest.
Description: RAMware modified implantable pulse generator (IPG)
Study NCT05236283 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Blood Culture
Description: Blood Culture
Study NCT06429579 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Comprehensive therapy combined Potts-shunt procedure and conventional drug therapy
Description: Potts-shunt procedure is the surgery that connect the descending aorta and the left/main pulmonary artery by direct anastomosis, a Gore-tex tube or a Gore-tex tube with flap.
Study NCT06429579 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Only conventional drug therapy
Description: Only conventional drug therapy (i.e., Prostacyclin analogues, PDE-5 inhibitors, and Endothelin receptor antagonists)
Study NCT06721962 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: TRX103
Description: TRX103 is an investigational research product that may treat and provide long term relief to individuals suffering from Crohn's Disease.
Study NCT06721962 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Low dose cyclophosphamide conditioning.
Study NCT06735976 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: PAVM Embolization
Description: This study consists of one group. All participants will undergo PAVM embolization with a LOBO™ device.
Study NCT06735976 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: PAVM Embolization with a LOBO™ device
Description: Participants will undergo PAVM embolization with the LOBO™ device per standard of care.
Study NCT06739122 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dulaglutide
Description: Administered SC
Study NCT06735638 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: OTC MIE Esophagectomy
Description: Consenting patients will undergo minimally invasive esophagectomy (MIE) using the Out of the Cage (OTC) robotic-assisted technique. The procedure will follow the exact standard steps of traditional VATS/RATS esophagectomy, except the thoracic ports will be placed in the subcostal plane. The number of ports (1-4) will be determined based on the patient and case characteristics.~The Da Vinci Xi® surgical system will be used to perform the thoracic portion of the esophagectomy through subcostal ports using the standard technique. Once the procedure is completed, the robotic arms and ports will be removed from the chest, and figure-of-8 stitches with non-absorbable sutures will be placed to close the diaphragm at the port sites. A 24 Fr soft chest tube will be left in place, as per standard VATS/RATS esophagectomy protocols. Incisions will be closed in the standard manner.
Study NCT06734117 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Elecsys® Troponin T hs Gen 6
Description: It is an immunoassay for the in vitro quantitative determination of cardiac troponin T (cTnT) in human serum and plasma using cobas e platforms. This investigational immunoassay is intended to aid in the diagnosis of myocardial infarction.
Study NCT06734117 — intervention group
Intervention type: PROCEDURE
Intervention: Blood sample collection
Description: Blood will be collected from each recruited individual by a healthcare practitioner at five time points after emergency department presentation.
Study NCT06746064 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CHF10073 (Part 1 - SAD)
Description: Single doses of CHF10073 for each cohort
Study NCT06746064 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo (Part 1 - SAD)
Description: Single doses of placebo matching CHF10073 for each cohort
Study NCT06746064 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CHF10073 (Part 2 - MAD)
Description: Multiple doses of CHF10073 for each cohort
Study NCT06746064 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CHF10073 (Part 3)
Description: Single dose of CHF10073
Study NCT06746064 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo (Part 2 - MAD)
Description: Multiple doses of placebo matching CHF10073 for each cohort
Study NCT06748963 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Fasted Exercise
Description: Participants will complete three sessions of combined resistance-aerobic exercise per week. Sessions will always start with resistance training followed by aerobic training, and will increase in duration throughout the intervention period, so that by the final three weeks of the intervention, all participants accumulate 150 minutes per week of moderate intensity aerobic exercise and 75 minutes of resistance exercise per week. Participants will complete three distinct resistance exercise sessions per week, which will increase in load, but decrease in repetition range throughout the trial. The aerobic component of the exercise sessions will increase in duration from 35 to 50 minutes per session. Participants will walk on a treadmill at a speed and incline that corresponds to 70-80% of ventilatory threshold.
Study NCT06748963 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Postprandial Exercise
Description: Participants will complete three sessions of combined resistance-aerobic exercise per week. Sessions will always start with resistance training followed by aerobic training, and will increase in duration throughout the intervention period, so that by the final three weeks of the intervention, all participants accumulate 150 minutes per week of moderate intensity aerobic exercise and 75 minutes of resistance exercise per week. Participants will complete three distinct resistance exercise sessions per week, which will increase in load, but decrease in repetition range throughout the trial. The aerobic component of the exercise sessions will increase in duration from 35 to 50 minutes per session. Participants will walk on a treadmill at a speed and incline that corresponds to 70-80% of ventilatory threshold.
Study NCT06745609 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Prehabilitation
Description: Pre-KiT prehabilitation consists of~1. A geriatric guided assessment with relevant interventions. The assessment will include cognitive evaluation, screening for depression, functional assessment, as well as evaluation of nutritional risk, assessment of past and current diseases, and a thorough review of the patient's medication list focusing on drug interactions. It will also include social history and standard laboratory results,~2. Physical activity. A four week home exercise program, adjusted to the participants physical abilities.~3. Assisted smoking cessation
Study NCT06752720 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Stem cell Transplantation
Description: Manufactured autologous mescenchymal stem cell (HUNS001-01) in our cell processing center will be injected into the brain, totally 4 x 10\^7 cells, in 2 brain sites.
Study NCT06162624 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Description: ACT: Therapy that builds in traditional cognitive behavioral therapy principles but emphasizes different processes in behavior change. Delivered over 8 weeks of self-guided study and homework assignments.
Study NCT06162624 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Cognitive Behavioral Therapy (CBT)
Description: As control condition, CBT book Feeling Good Self-Help Book will be used
Study NCT06752018 — intervention group
Intervention type: PROCEDURE
Intervention: Gastric bypass
Description: Roux-en-Y gastric bypass or sleeve gastrectomy
Study NCT06752811 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: paclitaxel polymeric micelles for injection
Description: Paclitaxel polymeric micelles for injection at a dose of 300 mg/m2 (based on body surface area), administered on Day 1, with intravenous infusion for ≥ 3 hours, every 3 weeks as a cycle.
Study NCT06752811 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemcitabine Hydrochloride for Injection
Description: The subjects also need to receive intravenous infusion of gemcitabine hydrochloride combination therapy at a dose of 1000 mg/m2 (based on body surface area), administered at D1 and D8 every 3 weeks.
Study NCT06752811 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Paclitaxel for Injection (albumin bound )
Description: Patients in the control group will receive intravenous infusion of paclitaxel for Injection (albumin bound ) at a dose of 125 mg/m2 (based on body surface area), administered at D1, D8, and D15, every 4 weeks as a cycle.
Study NCT06752811 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Gemcitabine Hydrochloride for Injection
Description: The subjects also need to receive intravenous infusion of gemcitabine hydrochloride combination therapy at a dose of 1000 mg/m2 (based on body surface area), administered at D1, D8, and D15 every 4 weeks.
Study NCT06765863 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Human Milk Fortifier
Description: Human milk fortifier added to expressed human milk (mother's own milk or pasteurized donor human milk) per feed per manufacturer's instructions for a minimum of 21 days (in-facility provision only)~* Clinical feeding guideline including targets for initiation and advancement of breast milk feeding~* Provision of guideline-driven standard of care \[facility-based lactation support/feeding counseling + KMC + WASH package (referred to as facility-based FSP+) and breast pumps\]
Study NCT06765863 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Volume targets
Description: * Clinical feeding guideline including targets for initiation and advancement of breast milk feeding~* Provision of guideline-driven standard of care \[facility-based lactation support/feeding counseling + KMC + WASH package (referred to as facility-based FSP+) and breast pumps\]
Study NCT06765863 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Volume targets
Description: * Clinical feeding guideline including targets for initiation and advancement of breast milk feeding~* Provision of guideline-driven standard of care \[facility-based lactation support/feeding counseling + KMC + WASH package (referred to as facility-based FSP+) and breast pumps\]
Study NCT06764745 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PC Ventilation Modes
Description: Following induction, Group I patients received mechanical ventilation using the PC mode. The anesthetic machine (MAQUET Flow-I, Italy) parameters were set as follows: The inspiratory pressure (Pins) was adjusted to maintain an end-tidal carbon dioxide concentration (ETCO2) of 4.0-5.0 kPa. Pure oxygen and air were utilized at 0.3 L/min each, with an oxygen content of 41%. The positive end-expiratory pressure (PEEP) was set at 10 cmH2O, with an inspiration-to-expiration ratio of 1:2, a respiratory rate of 16 breaths per minute, and an oxygen content of 41%.
Study NCT04755933 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Raising Confident Children Course
Description: An online learning tool consisting of 8 different modular components, designed to reduce the transmission of anxiety from parents to children. The modular components include: a core starter about anxiety, the role of avoidance, using play to develop childrens confidence, using Emotion Coaching with children, managing difficult behaviour, the role of sleep, exercise and diet, reducing overprotection, modelling confident behaviour and managing difficult behaviour.
Study NCT06764745 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: VC Ventilation Modes
Description: Following induction, Group II patients received mechanical ventilation using the VC mode. The anesthetic machine (MAQUET Flow-I, Italy) parameters were set as follows: The inspiratory pressure (Pins) was adjusted to maintain an end-tidal carbon dioxide concentration (ETCO2) of 4.0-5.0 kPa. Pure oxygen and air were utilized at 0.3 L/min each, with an oxygen content of 41%. The positive end-expiratory pressure (PEEP) was set at 10 cmH2O, with an inspiration-to-expiration ratio of 1:2, a respiratory rate of 16 breaths per minute, and an oxygen content of 41%.
Study NCT06764745 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PRVC Ventilation Modes
Description: Following induction, Group III patients received mechanical ventilation using the PRVC mode. The anesthetic machine (MAQUET Flow-I, Italy) parameters were set as follows: The inspiratory pressure (Pins) was adjusted to maintain an end-tidal carbon dioxide concentration (ETCO2) of 4.0-5.0 kPa. Pure oxygen and air were utilized at 0.3 L/min each, with an oxygen content of 41%. The positive end-expiratory pressure (PEEP) was set at 10 cmH2O, with an inspiration-to-expiration ratio of 1:2, a respiratory rate of 16 breaths per minute, and an oxygen content of 41%.
Study NCT06764147 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ET-26HCl
Description: The dose is 0.8 mg/kg, single dose, Infusion time was 60s ± 5s.
Study NCT06768762 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Phone Coaching
Description: Participants will receive 11 coaching calls with a health coach. Calls will occur weekly during the first month, twice/month during months 2-3, and once/month during months 4-6. Each call is expected to last 10-15 minutes.
Study NCT06768762 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Progress reports to providers
Description: Progress reports on physical activity and program adherence will be sent to participants providers at 3 and 6 months.